CROI 2017 Program and Information

Program and Agenda

807 PHARMACOKINETICS OF RILPIVIRINE AFTER SWITCHING FROM EFAVIRENZ IN ADOLESCENTS Watsamon Jantarabenjakul 1 , Narukjaporn Thammajaruk 2 , Torsak Bunupuradah 2 , Jiratchaya Sophonphan 2 , Tim R. Cressey 3 , Angela Colbers 4 , David M. Burger 4 , Wanatpreeya Phongsamart 5 , Thanyawee Puthanakit 1 , Chitsanu Pancharoen 1 1 Chulalongkorn Univ, Bangkok, Thailand, 2 HIV Netherlands Australia Thailand Rsr Collab,Thai Red Cross AIDS Rsr, Bangkok, Thailand, 3 Prog for HIV Prevention and Treatment, Chiang Mai, Thailand, 4 Radboud Univ, Nijmegen, Netherlands, 5 Mahidol Univ, Bangkok, Thailand 808 NEVIRAPINE PK, VIROLOGICAL OUTCOME, AND AEs IN AFRICAN CHILDREN ON PAEDIATRIC FDCs Andrzej Bienczak 1 , Paolo Denti 1 , Adrian Cook 2 , Lubbe Wiesner 1 , Diana Gibb 2 , David M. Burger 3 , Sarah Walker 2 , Helen Mcilleron 1 , for the CHAPAS-3 Study Team 1 Univ of Cape Town, Cape Town, South Africa, 2 Univ Coll London, London, UK, 3 Radboud Univ Med Cntr, Nijmegen, Netherlands 809 AN EASY-TO-USE PAEDIATRIC DOSING TOOL: ONEMG/KG DOSE DOES NOT FIT ALL 1 Univ of Cape Town, Cape Town, South Africa, 2 Clinton Hlth Access Initiative, New York, NY, USA, 3 Prog for HIV Prevention and Treatment, Chiang Mai, Thailand, 4 Boston Med Cntr, Boston, MA, USA, 5 Univ of California San Diego, La Jolla, CA, USA, 6 WHO, Geneva, Switzerland 810 SERTRALINE PHARMACOKINETICS INHIV-INFECTED ON ARV AND UNINFECTED YOUTH Nathan Hanan 1 , Mary Paul 2 , Yanling Huo 3 , Edmund Capparelli 1 , Suad Kapetanovic 4 , J. L. Ariansen 5 , Elizabeth Smith 6 , Pim Brouwers 4 , Brookie Best 1 , for the IMPAACT P1080 Protocol Team 1 Univ of California San Diego, La Jolla, CA, USA, 2 Baylor Coll of Med, Houston, TX, USA, 3 Harvard Univ, Boston, MA, USA, 4 NIMH, Rockville, MD, USA, 5 FHI 360, Durham, NC, USA, 6 NIAID, Rockville, MD, USA Paolo Denti 1 , Nandita Sugandhi 2 , Tim R. Cressey 3 , Mark Mirochnick 4 , Edmund V. Capparelli 5 , Martina Penazzato 6 , for the Paediatric ARV Working Group Claire Pressiat 1 , Véronique Mea-Assande 2 , Caroline Yonaba 3 , Jean-Marc Treluyer 4 , Désiré Lucien Dahourou 5 , Madeleine Amorissani-Folquet 6 , Stephane Blanche 7 , Valeriane Leroy 8 , Déborah Hirt 9 , for the MONOD Study Group 1 Paris Descartes Univ, Paris, France, 2 PACCI Prog, Abidjan, Cote d’Ivoire, 3 CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso, 4 Paris Cntr Hosp Group, Paris, France, 5 Cntr de Rsr Intl Pour la Santé, Ouagadougou, Burkina Faso, 6 CHU of Cocody, Abidjan, Cote d’Ivoire, 7 Necker Hosp, Paris, France, 8 INSERM, Toulouse, France, 9 Paris Cntr Hosp Group, Paris, France 811 SUBOPTIMAL COTRIMOXAZOLE PROPHYLACTIC CONCENTRATIONS IN CHILDREN

Poster Sessions • Thursday

CROI 2017 198